Phone: +46 46 222 07 58
Visiting address: Skånes universitetssjukhus, Lund
This project aims to develop incretin therapy as a glucose-reducing strategy in type 2 diabetes (T2D). Its particular focus is to understand the mechanisms of incretin therapy and to optimize its clinical positioning. This mission is achieved by an interdisciplinary approach with complementary studies in subjects with T2D, healthy volunteers and experimental animals.
- Research project participantwathik [dot] alsalim [at] med [dot] lu [dot] se
- Research project participantkristina [dot] andersson [at] med [dot] lu [dot] se
- Research project participantjohan [dot] farngren [at] med [dot] lu [dot] se